Literature DB >> 10963817

Survey of mRNAs encoding zinc transporters and other metal complexing proteins in pancreatic islets of rats from birth to adulthood: similar patterns in the Sprague-Dawley and Wistar BB strains.

K S Clifford1, M J MacDonald.   

Abstract

The zinc content in the pancreatic beta cell is among the highest of the body, but information about which proteins might handle zinc in the beta cell is unknown. In the present work RT-PCR was used to obtain clues about the developmental expression of genes encoding metal complexing proteins in the pancreatic islets of the normal Sprague-Dawley rat and the BB diabetes resistant (BBDR) rat. The BBDR rat possesses beta cells genetically identical to the BB diabetes prone (BBDP) rat which exhibits an autoimmune diabetes quite similar to type 1 diabetes in humans, but in contrast to the BBDP rat, the islets of the BBDR rat are amenable to study because they are not destroyed by immune attack. There was no difference in the expression of any of the genes studied between the two strains of rats. mRNAs encoding zinc transport proteins ZnT-1 and ZnT-4, as well as calreticulin, ferritin heavy and light chains, metallothionein 1, metallothionein 3, Nramp1, Nramp2, transferrin, and the transferrin receptor were readily detected in pancreatic islets of 10-day-old, 5-week-old, and adult (60 to 90-day-old) rats. In contrast to the islet, mRNAs encoding metallothionein 3, Nramp1, Nramp2, ZnT-2, ZnT-3, and ZnT-4 and transferrin were not detected in the whole pancreas of adult Sprague-Dawley rats. In the whole pancreas of 3-day-old rats, ZnT-1 was the only zinc transporter mRNA detected and its level was moderate. Moderate to high levels of mRNA encoding calreticulin and the light and heavy chains of ferritin, as well as transferrin and the transferrin receptor, were detected in whole pancreas at 3 days. ZnT-2 and ZnT-3 mRNAs were present in low to moderate levels in pancreatic islets of 10-day and 5-week-old rats, but were absent in 3-day-old pancreas and islets of adult animals. These results indicate that expression of these proteins is developmentally regulated in the islet. In both Sprague-Dawley and BB rats, high levels of mRNAs encoding known beta cell proteins as controls (cytochrome b558, quinone reductase, the tricarboxylic acid transport protein and the receptors for IGF-1 and IGF-2 and insulin) were present in islets from 10 days to adulthood. Levels of mRNAs encoding quinone reductase, the tricarboxylic acid transport protein cytochrome b558 and the receptors for IGF-2 and insulin, were low or absent in 3-day-old and adult pancreas. BB rats were studied in an attempt to discern a difference between normal rats and the BB strain of rats, because, perhaps, delayed expression of a beta cell protein results in failure of immune tolerance against the beta cell. According to this paradigm none of the proteins examined in the current study appear to be a candidate for initiating an immune response in the BB rat.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963817     DOI: 10.1016/s0168-8227(00)00141-8

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

1.  Widespread expression of zinc transporter ZnT (SLC30) family members in mouse endocrine cells.

Authors:  Man-Li Zhong; Zhi-Hong Chi; Zhong-Yan Shan; Wei-Ping Teng; Zhan-You Wang
Journal:  Histochem Cell Biol       Date:  2012-06-07       Impact factor: 4.304

Review 2.  Zinc and zinc transporter regulation in pancreatic islets and the potential role of zinc in islet transplantation.

Authors:  Mariea D Bosco; Daisy M Mohanasundaram; Chris J Drogemuller; Carol J Lang; Peter D Zalewski; P Toby Coates
Journal:  Rev Diabet Stud       Date:  2011-02-10

Review 3.  Islet autoantigens: structure, function, localization, and regulation.

Authors:  Peter Arvan; Massimo Pietropaolo; David Ostrov; Christopher J Rhodes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

4.  SLC30A3 responds to glucose- and zinc variations in beta-cells and is critical for insulin production and in vivo glucose-metabolism during beta-cell stress.

Authors:  Kamille Smidt; Niels Jessen; Andreas Brønden Petersen; Agnete Larsen; Nils Magnusson; Johanne Bruun Jeppesen; Meredin Stoltenberg; Janetta G Culvenor; Andrew Tsatsanis; Birgitte Brock; Ole Schmitz; Lise Wogensen; Ashley I Bush; Jørgen Rungby
Journal:  PLoS One       Date:  2009-05-25       Impact factor: 3.240

5.  Incomplete glycosylation and defective intracellular targeting of mutant solute carrier family 11 member 1 (Slc11a1).

Authors:  Jacqueline K White; Abigail Stewart; Jean-Francois Popoff; Shona Wilson; Jenefer M Blackwell
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

6.  The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.

Authors:  Janet M Wenzlau; Kirstine Juhl; Liping Yu; Ong Moua; Suparna A Sarkar; Peter Gottlieb; Marian Rewers; George S Eisenbarth; Jan Jensen; Howard W Davidson; John C Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

7.  Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function.

Authors:  Carmel B Stober; Sven Brode; Jacqueline K White; Jean-François Popoff; Jenefer M Blackwell
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

Review 8.  Mammalian Metallothionein-3: New Functional and Structural Insights.

Authors:  Milan Vašák; Gabriele Meloni
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

9.  Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?

Authors:  Laerke Egefjord; Jens Ledet Jensen; Claus Heiner Bang-Berthelsen; Andreas Brønden Petersen; Kamille Smidt; Ole Schmitz; Allan Ertman Karlsen; Flemming Pociot; Fabrice Chimienti; Jørgen Rungby; Nils E Magnusson
Journal:  BMC Endocr Disord       Date:  2009-02-25       Impact factor: 2.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.